.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Post-Conference Perspectives: Update on PARP Inhibitors in Breast Cancer

EP. 1: A PARP/I-O Strategy in Breast Cancer: The MEDIOLA Trial

December 28th 2018

EP. 2: PARP Inhibition as Neoadjuvant Therapy in Breast Cancer

December 28th 2018

EP. 3: Adding Olaparib to Chemotherapy in TNBC: The PARTNER Trial

December 28th 2018

EP. 4: PARP/Checkpoint Inhibition in TNBC: The TOPACIO Trial

December 28th 2018

EP. 5: Future Roles of PARP Inhibition in Breast Cancer

December 28th 2018